Hepatobiliary system-liver and pancreas and gall bladder and ducts, percutaneous approach

85813200 Category Share

Hepatobiliary system-liver and pancreas and gall bladder and ducts, percutaneous approach is an EFRIS commodity class (code 85813200) under Administrative interventions or procedures, physiological systems and anatomical regions, introduction and irrigation and circulatory in Uganda Revenue Authority's e-invoicing system.

17 items in this category

• 85813205Introduction of analgesics, hypnotics, sedatives into biliary and pancreatic tract, percutaneous approach
  Exempt
• 85813212Introduction of anti-inflammatory into biliary and pancreatic tract, percutaneous approach
  Exempt
• 85813202Introduction of autologous pancreatic islet cells into biliary and pancreatic tract, percutaneous approach
  Exempt
• 85813203Introduction of destructive agent into biliary and pancreatic tract, percutaneous approach
  Exempt
• 85813210Introduction of electrolytic and water balance substance into biliary and pancreatic tract, percutaneous approach
  Exempt
• 85813217Introduction of liquid brachytherapy radioisotope into biliary and pancreatic tract, percutaneous approach
  Exempt
• 85813209Introduction of local anesthetic into biliary and pancreatic tract, percutaneous approach
  Exempt
• 85813215Introduction of monoclonal antibody into biliary and pancreatic tract, percutaneous approach
  Exempt
• 85813201Introduction of nonautologous pancreatic islet cells into biliary and pancreatic tract, percutaneous approach
  Exempt
• 85813211Introduction of nutritional substance into biliary and pancreatic tract, percutaneous approach
  Exempt
• 85813213Introduction of other anti-infective into biliary and pancreatic tract, percutaneous approach
  Exempt
• 85813216Introduction of other antineoplastic into biliary and pancreatic tract, percutaneous approach
  Exempt
• 85813206Introduction of other diagnostic substance into biliary and pancreatic tract, percutaneous approach
  Exempt
• 85813204Introduction of other gas into biliary and pancreatic tract, percutaneous approach
  Exempt
• 85813208Introduction of other therapeutic substance into biliary and pancreatic tract, percutaneous approach
  Exempt
• 85813214Introduction of oxazolidinones into biliary and pancreatic tract, percutaneous approach
  Exempt
• 85813207Introduction of radioactive substance into biliary and pancreatic tract, percutaneous approach
  Exempt